FutureCeuticals and Global Calcium have announced a strategic global sales and manufacturing partnership to expand FutureCeuticals’ portfolio of supplement ingredients into India, Southeast Asia, the Middle East, and Africa. The partnership will leverage Global Calcium’s manufacturing and sales network.
 
The partnership will initially focus on FruiteX-B calcium fructoborate, a patented and clinically-supported mineral complex by FutureCeuticals, which has been featured in bone, joint, and mobility support products.
 
“We are thrilled to partner with Global Calcium, extending the reach of our innovative ingredient solutions,” said J. Randal Wexler, vice president and head of research and development at FutureCeuticals. “Their world-class manufacturing capabilities align with our high standards, and this opens doors to some of the world’s fastest-growing markets. The decision to utilize their capabilities to help us globalize our industry-leading and innovative joint and bone mineral complex made perfect sense.”
 
“We are excited to collaborate with a globally recognized innovator like FutureCeuticals on this strategic venture,” said Sahil Vaz, CEO of Global Calcium. “Their science-based platform of research-backed ingredients aligns perfectly with our manufacturing capabilities and business strengths. Our initial focus on FutureCeueticals’ FruiteX-B calcium fructoborate provides a compelling new joint and bone solution that is a natural extension of our existing, market-leading specialty mineral actives offerings.”